I am really curious what will happen to price if/when they annouce partnership. We already know that GIA most likely causes price to drop below $2, with slow recovery. Buy-out is an easy one to figure out. But what happens with partnership news. Is it one of those cases where people so happy to finally have some good news that price doubles. Or are people so disenfranchised at this point that we get a decent 10-20% boost and quickly retreats. Partnership is better than GIA short-term, but in both cases we still have to wait until sales start coming in to see a true growth in share price. That is why I am hoping after all this waiting that it is a clean buy-out and everyone makes a nice profit and moves on with their lives, and I can end my addiction. Thoughts?
Riidiculous question. Partnership with what party? On what terms? You can strike a great partnership deal or get hosed by BP so no answer can be derived. And buy out is an easy one to figure out? Really? First of all, there is a 0% chance of a buy out at this point since max price right now would be $4 and they have no interest in selling the company at $4.
Hey smart guy, what I meant was if they announce buy out, we will know the price so that is why it is easy to figure out. I disagree with you on 0% buy out chance. It is not strictly based off share price, especially the exact current share price. What if this went up to 3.50 tomorrow, suddenly call BP back because now we can get 7. It is based on worth of company and its products. And if there are a few companies interested, could be bidding, could raise price. I am not saying 15-20 right now, but 7-10 is realistic IMO.
I think it doubles on partnership news. Doesn't really move until sales come in. Good upside but some downside too. Go it alone and dilution are a concern if no partner by year end. Money will become a concern at some point.
ozz: I strongly believe that "Z" is the game changer that we envision it to be. Sales will be all that matter at the end of the day, If the medical profession endorses it and the payers see a financial saving in a 100-150 dollar patch vs. emergency room care, lost productivity of the patient then PATH has a long growth curve just with this one application. So I don't expect much until next year when we can see how this all plays out. We all know what the market potential is now can the co. get the right partner with the existing sales force to get us there. questions & more questions. A partnership with the right terms puts us in play but sales next year and beyond are all that matter. peace